Edgewise Therapeutics: Solid Data, Decent Cash, Great Management Profile (NASDAQ:EWTX)

PeopleImages/iStock via Getty Images

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) is a developer of small molecule therapies for musculoskeletal diseases. The pipeline looks like this:

EWTX pipeline

EWTX pipeline (EWTX website)

That’s basically one molecule – EDG-5506 – in four indications:

DMD – Duchenne muscular dystrophy

EWTX study differences

EWTX study differences (EWTX website)

Leave a Reply

Your email address will not be published. Required fields are marked *